Adicet Bio (ACET) Interest Coverage Ratio (2017 - 2026)
Adicet Bio (ACET) posted quarterly Interest Coverage Ratio of 1.43 for Q1 2026, up 84.44% year-over-year from 0.78 in Q1 2025, and up 99.89% quarter-over-quarter from 1328.58 in Q4 2025.
Adicet Bio (ACET) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Adicet Bio's Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 1.43 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 84.44% year-over-year to 1.43; the TTM figure through Mar 2026 stood at 7.57 (up 80.62% YoY), while the FY2025 annual figure was 0.87, up 18.77% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 1.43, up from 1328.58 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.15 in Q1 2022, with the low at 1328.58 in Q4 2025.
- The 5-year median for Interest Coverage Ratio is 4.54 (2023), against an average of 88.35.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio jumped 106.47% in 2022, then tumbled 17173.36% in 2025.
- Adicet Bio's Interest Coverage Ratio stood at 8.21 in 2022, then dropped by 21.99% to 10.01 in 2023, then increased by 23.18% to 7.69 in 2024, then sank by 17173.36% to 1328.58 in 2025, then surged by 99.89% to 1.43 in 2026.
- Business Quant data shows ACET's Interest Coverage Ratio at 1.43 in Q1 2026, 1328.58 in Q4 2025, and 23.79 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | -1,013.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.60 |
| Mar 31, 2026 | -1.43 |
| Dec 31, 2025 | -1,328.58 |
| Sep 30, 2025 | -23.79 |
| Jun 30, 2025 | -1.78 |
| Mar 31, 2025 | -9.22 |
| Dec 31, 2024 | -7.69 |
| Sep 30, 2024 | -1.50 |
| Jun 30, 2024 | -7.89 |
| Mar 31, 2024 | -1.26 |
| Sep 30, 2023 | -10.01 |
| Jun 30, 2023 | -6.31 |
| Mar 31, 2023 | -2.76 |
| Dec 31, 2022 | -8.21 |
| Sep 30, 2022 | -1.67 |
| Jun 30, 2022 | -1.65 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | -621.68 |
| Sep 30, 2021 | -1.90 |
| Jun 30, 2021 | -2.19 |